Global vaccine trends: R&D and market insights driving new opportunities

Vaccines save millions of lives each year. By providing large-scale protection against serious diseases, vaccination programs proved to be one of the greatest public health achievements of the 20th century. Thanks to the advent of recombinant DNA technology and advanced multivalent vaccines, coupled with the ground-breaking innovation of cancer vaccines, the scope of vaccines continues to expand.

Top 5 COVID-19 vaccine questions answered

CAS launches new brand reflecting strategic evolution to empower smarter science

CAS launched a new brand reflecting the broadening scope of its solutions and capabilities critical to advancing scientific discovery. This new brand mirrors an on-going evolution to enable new and smarter uses of scientific information as a partner to R&D leaders pursuing more efficient, collaborative, and customized innovation models.

CAS Common Chemistry™ expands collection of publicly available chemical information

CAS has expanded the open access Common Chemistry resource to nearly 500,000 substances from CAS REGISTRY®. The collection represents substances commonly found in consumer products, regulatory lists, and introductory chemistry curricula.

New AI-Enabled Virtual Screening Tool Identifies Most Promising Approved Drugs for Success in Treating COVID-19

WorldQuant Predictive (WQP) and CAS have partnered to develop a groundbreaking methodology that can save time and lives by helping researchers rapidly prioritize the most promising drug candidates to treat COVID-19 and other critical diseases.

Scilligence Partners with CAS to Optimize R&D Informatics Workflows with Scientist-Curated Data

Scilligence, a provider of web-based informatics solutions for R&D, has partnered with CAS to enable direct access to CAS scientific content through the Scilligence informatics platform. This partnership builds on a previous collaboration by streamlining additional workflow scenarios. Users can now access CAS REGISTRY® data directly from Scilligence ELN and Scilligence Inventory.

MoA Technology integrates CAS chemical substance data into novel herbicide R&D workflow

CAS and MoA Technology, an innovator in herbicide R&D, announce an agreement to embed chemical substance data from the CAS REGISTRY®, as well as related reference and property information, directly into MoA’s R&D workflow via an application programming interface (API).

CAS announces signing of multi-year enterprise agreement with P&G

CAS announces signing of multi-year enterprise agreement with P&G that expands long-term partnership to support CPG leader’s commitment to disruptive innovation. Global access to leading scientific information solutions portfolio informs business strategy and fuels efficient R&D to deliver superior consumer product performance.

INPI and CAS Sign Technical Cooperation Agreement Formalizing Collaboration to Tackle Brazil’s Patent Application Backlog

The National Institute of Industrial Property (INPI) of Brazil and CAS have signed a formal Technical Cooperation Agreement to test and optimize the application of CAS technology to expedite patent examination.